EUP-31929-23589
5 vaccinations
13 coded responses
48 check-ins
13 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 982 / WA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Dose 2 — Pfizer-BioNTech
-
2021-03-08
Registered in v-safe
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Pre-existing hip tendinitis is way worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
-
2021-03-13
Health check-in — day 7, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-20
- 2021-03-28
- 2021-04-04
- 2021-04-10
- 2021-04-17
- 2021-06-05
-
2021-08-19
Dose 3 — Pfizer-BioNTech
- 2021-08-19
-
2021-08-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-21
- 2021-08-23
- 2021-08-24
- 2021-08-25
-
2021-08-26
Health check-in — day 7, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-02
- 2021-09-09
-
2021-09-16
Survey response — day 28, dose 3MedDRA: Bone pain, Fatigue, Myalgia, Tenderness — Feeling: Good · Be unable to do your normal daily activitiesFree text: Since last visafe check- in I experienced 4 days of lower leg muscle and bone pain, bilateral medial knee tenderness and fatigue. Now resolved.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Survey response — day 35, dose 3MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: GoodFree text: Peripheral neuropathy has been worse over past 4 daysMedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
-
2021-11-18
Survey response — 3 months, dose 3MedDRA: Lymphocyte percentage increased — Feeling: GoodFree text: My lymphocyte percentage popped up to over 70MedDRA releases: 2024-11 · check-in free text available
-
2022-02-03
Dose 4 — Moderna
-
2022-02-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2022-02-05
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-02-06
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-02-07
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-02-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-02-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-02-10
Survey response — day 7, dose 4MedDRA: Paraesthesia — Feeling: GoodFree text: I've got tingling in my lower legs/feet, right more than left, which began a few days ago.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-19
- 2022-02-24
- 2022-03-06
- 2022-03-10
-
2022-03-17
Survey response — day 42, dose 4MedDRA: Photopsia — Feeling: GoodFree text: I've been experiencing flashing slivers of light in my lower left visual field for several days.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Survey response — 3 months, dose 4MedDRA: Office visit, Vitreous haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Vitreous hemorrhage left eye · Healthcare visit (other): 2 visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-06
-
2022-06-15
Dose 5 — Moderna
-
2022-06-21
Health check-in — days 1–6 daily, dose 5Feeling: Good · None · Be unable to do your normal daily activitiesAdult check-in
- 2022-06-22
-
2022-06-29
Survey response — day 14, dose 5MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I have mild neuropathy of hands and feet which has flared tremendously in the past few weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-06
Survey response — day 21, dose 5MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: GoodFree text: Neuropathy had flaredMedDRA releases: 2024-11 · check-in free text available
-
2022-07-13
Survey response — day 28, dose 5MedDRA: Rash — Feeling: GoodFree text: Rash on face, resolvedMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Survey response — day 35, dose 5MedDRA: Arthritis, Hypoaesthesia, Muscle spasms — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Low back spasm and hip inflammation with numbness to left thighMedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Survey response — day 42, dose 5MedDRA: Arthralgia — Feeling: FairFree text: Joint painMedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Survey response — 3 months, dose 5MedDRA: Vitreous detachment — Feeling: GoodFree text: Vitreous detachment right eyeMedDRA releases: 2024-11 · check-in free text available
- 2022-12-14
- 2023-06-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
| 4 | 2022-02-03 | Moderna | No |
| 5 | 2022-06-15 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Pre-existing hip tendinitis is way worse
Release 9 — day 28, dose 3
Symptoms: Since last visafe check- in I experienced 4 days of lower leg muscle and bone pain, bilateral medial knee tenderness and fatigue. Now resolved.
Release 9 — day 35, dose 3
Symptoms: Peripheral neuropathy has been worse over past 4 days
Release 10 — 3 months, dose 3
Symptoms: My lymphocyte percentage popped up to over 70
Release 11 — day 7, dose 4
Systemic reaction (other): I've got tingling in my lower legs/feet, right more than left, which began a few days ago.
Release 11 — day 42, dose 4
Symptoms: I've been experiencing flashing slivers of light in my lower left visual field for several days.
Release 11 — 3 months, dose 4
Release 12 — day 14, dose 5
Symptoms: I have mild neuropathy of hands and feet which has flared tremendously in the past few weeks.
Release 12 — day 21, dose 5
Symptoms: Neuropathy had flared
Release 12 — day 28, dose 5
Symptoms: Rash on face, resolved
Release 12 — day 35, dose 5
Symptoms: Low back spasm and hip inflammation with numbness to left thigh
Release 12 — day 42, dose 5
Symptoms: Joint pain
Release 12 — 3 months, dose 5
Symptoms: Vitreous detachment right eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Bone pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Lymphocyte percentage increased | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Photopsia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Tenderness | · | · | ✓ |
| SD | Vitreous detachment | · | · | ✓ |
| SD | Vitreous haemorrhage | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release